ABBV
39
8
AKAM
50
7
CVX
44
-2
EQR
59
5
RHI
57
3
MAR
65
2
PLD
48
-5
WU
30
6
APA
24
3
DOV
68
7
HOG
33
4
NWS
69
7
DRI
48
3
BWA
46
2
AMGN
38
-6
FMC
33
2
GT
56
2
LMT
32
-12
HPE
61
6
GIS
28
2
ABBV
39
8
AKAM
50
7
CVX
44
-2
EQR
59
5
RHI
57
3
MAR
65
2
PLD
48
-5
WU
30
6
APA
24
3
DOV
68
7
HOG
33
4
NWS
69
7
DRI
48
3
BWA
46
2
AMGN
38
-6
FMC
33
2
GT
56
2
LMT
32
-12
HPE
61
6
GIS
28
2
Financhill
Back

Neurogene Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
8

NGNE
Neurogene

Last Price:
20.28
Seasonality Move:
43.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Neurogene Stock Forecast

  • Over the next 52 weeks, Neurogene has on average historically risen by 24.3% based on the past 10 years of stock performance.
  • Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Neurogene Stock Undervalued?
    The current Neurogene [NGNE] share price is $20.30. The Score for NGNE is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Neurogene Stock Go Up Next Year?

  • Over the next 52 weeks, Neurogene has on average historically risen by 24.3% based on the past 10 years of stock performance.

Neurogene Stock Rating

Sell
8
Neurogene (NGNE) is a Sell

Is Neurogene overpriced?

  • Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Neurogene Stock Price History

Is NGNE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com

52-Week Data

52-Week High:
74.49
52-Week Low:
12.49

Prediction Charts

Market Cap:
301.55M
Price in USD:
20.30
Volume:
1.06M
Beta:
-1.26

Technical Analysis

SMA50:
44.77
SMA100:
41.48
SMA200:
38.66
52-Wk Change:
46.25%

Stock Predictions

  • Is Neurogene stock public?
    Yes, Neurogene is a publicly traded company.
  • What is the Neurogene stock quote today?
    The Neurogene stock price is 20.30 USD today.
  • How to buy Neurogene stock online?
    You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 65.44 64.40 65.64 55.88
Nov-6 66.36 63.94 66.36 62.13
Nov-7 63.99 69.50 70.80 62.84
Nov-8 69.78 68.21 71.60 66.60
Nov-11 70.04 71.53 74.49 69.49
Nov-12 48.28 40.00 49.37 35.60
Nov-13 39.67 39.54 41.33 39.08
Nov-14 39.50 39.20 43.24 38.97
Nov-15 38.84 34.52 39.20 34.52
Nov-18 22.24 19.82 23.79 18.94
Nov-19 20.90 17.23 20.99 17.01
Nov-20 17.31 15.33 17.45 15.28
Nov-21 15.06 15.59 16.15 14.44
Nov-22 15.48 20.30 20.93 15.48

Neurogene Earnings

Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.

Neurogene Forecast Revenue Growth

Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.

* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.